Floatz logo

Anti-Meso-Car Vector Transduced T Cells

Other Mesothelin Positive Tumors

Chinese PLA General HospitalCell therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Other Mesothelin Positive Tumors cohort.

Asset / SponsorPhaseRating
Temsirolimus
M.D. Anderson Cancer Center
Phase 1CC
Cetuximab
M.D. Anderson Cancer Center
Phase 1CC
Valproic Acid
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

Anti-Meso-Car Vector Transduced T Cells is also rated in:

malignant mesotheliomaDormant
CC
Indicative ·
43 / 100
View asset →
ovarian neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
triple-negative breast carcinomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →